Lataa...
Tackling COVID-19 with neutralizing monoclonal antibodies
Monoclonal antibodies (mAbs) have revolutionized the treatment of several human diseases, including cancer and autoimmunity and inflammatory conditions, and represent a new frontier for the treatment of infectious diseases. In the last 20 years, innovative methods have allowed the rapid isolation of...
Tallennettuna:
| Julkaisussa: | Cell |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8152891/ https://ncbi.nlm.nih.gov/pubmed/34087172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2021.05.005 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|